FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891867142> ?p ?o ?g. }

• W2891867142 abstract "The present study aimed to examine the influence of neomangiferin on murine calvarial inflammatory osteolysis induced by ultra-high-molecular-weight polyethylene (UHMWPE) particles. Eight-week-old male C57BL/J6 mice served as an inflammatory osteolysis model, in which UHMWPE particles were implanted into the calvarial subperiosteal space. The mice were randomly distributed into four groups and treated with different interventions; namely, a sham group [phosphate-buffered saline (PBS) injection and no UHMWPE particles], model group (PBS injection and implantation of UHMWPE particles), low-dose neomangiferin group (UHMWPE particles +2.5 mg/kg neomangiferin), and high-dose neomangiferin group (UHMWPE particles +5 mg/kg neomangiferin). Following 3 weeks of feeding according to the above regimens, celiac artery blood samples were collected for an enzyme-linked immunosorbent assay (ELISA) to determine the expression of receptor activator of nuclear factor-κB ligand (RANKL), osteoclast-related receptor (OSCAR), cross-linked C-telopeptide of type I collagen (CTX-1); osteoprotegerin (OPG), tumor necrosis factor (TNF)-α, and interleukin (IL)-1β. Subsequently, the mice were sacrificed by cervical dislocation following ether-inhalation anesthesia, and the skull was separated for osteolysis analysis by micro-computed tomography (micro-CT). Following hematoxylin and eosin staining, tartrate-resistant acid phosphatase (TRAP) staining was performed to observe the dissolution and destruction of the skull. The micro-CT results suggested that neomangiferin significantly inhibited the murine calvarial osteolysis and bone resorption induced by UHMWPE particles. In addition, the ELISA results showed that neomangiferin decreased the expression levels of osteoclast markers RANKL, OSCAR, CTX-1, TNF-α and IL-1β. By contrast, the levels of OPG increased with the neomangiferin dose. Histopathological examination revealed that the TRAP-positive cell count was significantly reduced in the neomangiferin-treated animals compared with that in the positive control group, and the degree of bone resorption was also markedly reduced. Neomangiferin was found to have significant anti-inflammatory effects and to inhibit osteoclastogenesis. Therefore, it has the potential to prevent the aseptic loosening of a prosthesis following artificial joint replacement." @default.
• W2891867142 created "2018-09-27" @default.
• W2891867142 creator A5009359919 @default.
• W2891867142 creator A5014470814 @default.
• W2891867142 creator A5015195367 @default.
• W2891867142 creator A5047460101 @default.
• W2891867142 creator A5060318276 @default.
• W2891867142 creator A5062682511 @default.
• W2891867142 creator A5077871678 @default.
• W2891867142 creator A5088919704 @default.
• W2891867142 date "2018-09-11" @default.
• W2891867142 modified "2023-10-16" @default.
• W2891867142 title "A study on the prevention and treatment of murine calvarial inflammatory osteolysis induced by ultra‑high‑molecular‑weight polyethylene particles with neomangiferin" @default.
• W2891867142 cites W1758276508 @default.
• W2891867142 cites W1851135258 @default.
• W2891867142 cites W1885826309 @default.
• W2891867142 cites W1974840323 @default.
• W2891867142 cites W199459570 @default.
• W2891867142 cites W2005968626 @default.
• W2891867142 cites W2023674113 @default.
• W2891867142 cites W2027170252 @default.
• W2891867142 cites W2031037805 @default.
• W2891867142 cites W2034824472 @default.
• W2891867142 cites W2035956857 @default.
• W2891867142 cites W2039407261 @default.
• W2891867142 cites W2054757511 @default.
• W2891867142 cites W2056262838 @default.
• W2891867142 cites W2061014186 @default.
• W2891867142 cites W2078238864 @default.
• W2891867142 cites W2083470031 @default.
• W2891867142 cites W2085125322 @default.
• W2891867142 cites W2091162166 @default.
• W2891867142 cites W2093166833 @default.
• W2891867142 cites W2093252878 @default.
• W2891867142 cites W2099783835 @default.
• W2891867142 cites W2110292281 @default.
• W2891867142 cites W2117258058 @default.
• W2891867142 cites W2130007618 @default.
• W2891867142 cites W2139510860 @default.
• W2891867142 cites W2144595959 @default.
• W2891867142 cites W2155407923 @default.
• W2891867142 cites W2158193380 @default.
• W2891867142 cites W2161655173 @default.
• W2891867142 cites W2174128729 @default.
• W2891867142 cites W2203063157 @default.
• W2891867142 cites W2256742438 @default.
• W2891867142 cites W2259566476 @default.
• W2891867142 cites W2275427756 @default.
• W2891867142 cites W2281139595 @default.
• W2891867142 cites W2339210813 @default.
• W2891867142 cites W2343417556 @default.
• W2891867142 cites W2347169975 @default.
• W2891867142 cites W2366349970 @default.
• W2891867142 cites W2472990867 @default.
• W2891867142 cites W2621186180 @default.
• W2891867142 cites W2725782188 @default.
• W2891867142 cites W2737572236 @default.
• W2891867142 cites W2767602840 @default.
• W2891867142 cites W2776967789 @default.
• W2891867142 cites W4290203128 @default.
• W2891867142 doi "https://doi.org/10.3892/etm.2018.6725" @default.
• W2891867142 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6200963" @default.
• W2891867142 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30402145" @default.
• W2891867142 hasPublicationYear "2018" @default.
• W2891867142 type Work @default.
• W2891867142 sameAs 2891867142 @default.
• W2891867142 citedByCount "1" @default.
• W2891867142 countsByYear W28918671422022 @default.
• W2891867142 crossrefType "journal-article" @default.
• W2891867142 hasAuthorship W2891867142A5009359919 @default.
• W2891867142 hasAuthorship W2891867142A5014470814 @default.
• W2891867142 hasAuthorship W2891867142A5015195367 @default.
• W2891867142 hasAuthorship W2891867142A5047460101 @default.
• W2891867142 hasAuthorship W2891867142A5060318276 @default.
• W2891867142 hasAuthorship W2891867142A5062682511 @default.
• W2891867142 hasAuthorship W2891867142A5077871678 @default.
• W2891867142 hasAuthorship W2891867142A5088919704 @default.
• W2891867142 hasBestOaLocation W28918671421 @default.
• W2891867142 hasConcept C125473707 @default.
• W2891867142 hasConcept C126322002 @default.
• W2891867142 hasConcept C141071460 @default.
• W2891867142 hasConcept C142724271 @default.
• W2891867142 hasConcept C160160445 @default.
• W2891867142 hasConcept C170493617 @default.
• W2891867142 hasConcept C17991360 @default.
• W2891867142 hasConcept C180675623 @default.
• W2891867142 hasConcept C181199279 @default.
• W2891867142 hasConcept C185592680 @default.
• W2891867142 hasConcept C2776033226 @default.
• W2891867142 hasConcept C2779428903 @default.
• W2891867142 hasConcept C2780426850 @default.
• W2891867142 hasConcept C2781282405 @default.
• W2891867142 hasConcept C55493867 @default.
• W2891867142 hasConcept C673006 @default.
• W2891867142 hasConcept C71924100 @default.
• W2891867142 hasConcept C74864618 @default.
• W2891867142 hasConcept C88045685 @default.
• W2891867142 hasConceptScore W2891867142C125473707 @default.
• W2891867142 hasConceptScore W2891867142C126322002 @default.
• W2891867142 hasConceptScore W2891867142C141071460 @default.

• next